{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:03:08Z","timestamp":1790679788415,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003976","name":"Israel National Institute for Health Policy Research","doi-asserted-by":"publisher","award":["NIHP-25-10"],"award-info":[{"award-number":["NIHP-25-10"]}],"id":[{"id":"10.13039\/501100003976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006297","name":"Maccabbi Healthcare Services","doi-asserted-by":"publisher","award":["MIHSR-250809"],"award-info":[{"award-number":["MIHSR-250809"]}],"id":[{"id":"10.13039\/501100006297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"USAID","doi-asserted-by":"crossref","award":["M-33-14"],"award-info":[{"award-number":["M-33-14"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206927","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T13:36:18Z","timestamp":1542029778000},"page":"e0206927","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR)"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4625-9742","authenticated-orcid":true,"given":"Rania","family":"Abu Seir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kifaya","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayob","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Namouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad","family":"Jaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmit","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Doron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Rahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-4607","authenticated-orcid":true,"given":"Gili","family":"Regev-Yochay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"issue":"9730","key":"ref1","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"RE Black","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"D Bogaert","year":"2004","journal-title":"The Lancet Infectious diseases"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1202938","article-title":"Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention","volume":"30","author":"JP Lynch 3rd","year":"2009","journal-title":"Seminars in respiratory and critical care medicine"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"B Simell","year":"2012","journal-title":"Expert review of vaccines"},{"key":"ref5","unstructured":"(IVAC) IVAC, Health JHBSoP. [8 August 2018]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.view-hub.org\" xlink:type=\"simple\">www.view-hub.org<\/ext-link>."},{"issue":"Suppl 5","key":"ref6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2012.03938.x","article-title":"Pneumococcal vaccines for children: a global public health priority","volume":"18","author":"LF Pittet","year":"2012","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.vaccine.2015.01.003","article-title":"Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR)","volume":"33","author":"M Daana","year":"2015","journal-title":"Vaccine"},{"issue":"25","key":"ref8","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2016.04.064","article-title":"Vaccine escape of piliated Streptococcus pneumoniae strains","volume":"34","author":"G Regev-Yochay","year":"2016","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2334-12-101","article-title":"Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada","volume":"12","author":"SR Earnshaw","year":"2012","journal-title":"BMC infectious diseases"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clinthera.2012.12.006","article-title":"Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden","volume":"35","author":"RM Klok","year":"2013","journal-title":"Clinical therapeutics"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"e0131156","DOI":"10.1371\/journal.pone.0131156","article-title":"Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines","volume":"10","author":"MA Haasis","year":"2015","journal-title":"PloS one"},{"issue":"23","key":"ref12","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.vaccine.2015.04.005","article-title":"Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada","volume":"33","author":"G Deceuninck","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"CM Domingues","year":"2014","journal-title":"The Lancet Respiratory medicine"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/cid\/cix685","article-title":"Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations","volume":"65","author":"P Naucler","year":"2017","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"43","key":"ref15","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1016\/j.vaccine.2017.09.005","article-title":"The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis","volume":"35","author":"C Alicino","year":"2017","journal-title":"Vaccine"},{"issue":"9546","key":"ref16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"CG Whitney","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"T Vesikari","year":"2009","journal-title":"The Pediatric infectious disease journal"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C","volume":"198","author":"IH Park","year":"2008","journal-title":"The Journal of infectious diseases"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/1471-2334-13-474","article-title":"The 7-valent pneumococcal conjugate vaccine elicits cross-functional opsonophagocytic killing responses to Streptococcus pneumoniae serotype 6D in children","volume":"13","author":"H Lee","year":"2013","journal-title":"BMC infectious diseases"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes","volume":"8","author":"LR Grant","year":"2013","journal-title":"PloS one"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2431-10-4","article-title":"Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?","volume":"10","author":"WP Hausdorff","year":"2010","journal-title":"BMC pediatrics"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine","volume":"26","author":"SI Pelton","year":"2007","journal-title":"The Pediatric infectious disease journal"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"MR Moore","year":"2008","journal-title":"The Journal of infectious diseases"},{"issue":"14","key":"ref24","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"MH Kyaw","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"18","key":"ref25","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.vaccine.2017.03.031","article-title":"The herd effects of infant PCV7\/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel","volume":"35","author":"G Regev-Yochay","year":"2017","journal-title":"Vaccine"},{"issue":"27","key":"ref26","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.vaccine.2014.03.065","article-title":"Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children &lt;5 years: an active prospective nationwide surveillance","volume":"32","author":"S Ben-Shimol","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2111.140780","article-title":"Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands","volume":"21","author":"MJ Knol","year":"2015","journal-title":"Emerging infectious diseases"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/INF.0b013e31823dcc72","article-title":"The changing epidemiology of invasive pneumococcal disease at a tertiary children&apos;s hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance","volume":"31","author":"K Ampofo","year":"2012","journal-title":"The Pediatric infectious disease journal"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines","volume":"14","author":"DJ Isaacman","year":"2010","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/INF.0b013e3182788fdd","article-title":"Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine","volume":"32","author":"D Sharma","year":"2013","journal-title":"The Pediatric infectious disease journal"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S2214-109X(14)70224-4","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","volume":"2","author":"LL Hammitt","year":"2014","journal-title":"The Lancet Global health"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"AB Brueggemann","year":"2004","journal-title":"The Journal of infectious diseases"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/1471-2334-13-492","article-title":"High incidence of septic shock caused by Streptococcus pneumoniae serotype 3\u2014a retrospective epidemiological study","volume":"13","author":"J Ahl","year":"2013","journal-title":"BMC infectious diseases"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3201\/eid2407.180029","article-title":"Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010\u20132015","volume":"24","author":"C Silva-Costa","year":"2018","journal-title":"Emerging infectious diseases"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"e00198","DOI":"10.1016\/j.heliyon.2016.e00198","article-title":"The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination","volume":"2","author":"HC Slotved","year":"2016","journal-title":"Heliyon"},{"issue":"40","key":"ref36","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.vaccine.2014.07.060","article-title":"Serotype epidemiology of invasive pneumococcal disease in Swiss adults: a nationwide population-based study","volume":"32","author":"J Meichtry","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"NJ Andrews","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"R Dagan","year":"2013","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"PA Waight","year":"2015","journal-title":"The Lancet Infectious diseases"},{"issue":"38","key":"ref40","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2015.07.080","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska","volume":"33","author":"MG Bruce","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"SS Huang","year":"2005","journal-title":"Pediatrics"},{"issue":"9807","key":"ref42","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"DM Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"60 e9","DOI":"10.1016\/j.cmi.2015.08.027","article-title":"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA","volume":"22","author":"BJ Metcalf","year":"2016","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"17","key":"ref44","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"RA Gladstone","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"S Flasche","year":"2011","journal-title":"PLoS medicine"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children","volume":"124","author":"SS Huang","year":"2009","journal-title":"Pediatrics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nmni.2015.11.001","article-title":"Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan","volume":"9","author":"M Kawaguchiya","year":"2016","journal-title":"New microbes and new infections"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3345\/kjp.2014.57.2.55","article-title":"Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines","volume":"57","author":"H Lee","year":"2014","journal-title":"Korean journal of pediatrics"},{"issue":"46","key":"ref49","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1016\/j.vaccine.2016.09.027","article-title":"Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in Sao Paulo, Brazil","volume":"34","author":"MC Brandileone","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010215","article-title":"The pneumococcus: epidemiology, microbiology, and pathogenesis","volume":"3","author":"B Henriques-Normark","year":"2013","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"e60520","DOI":"10.1371\/journal.pone.0060520","article-title":"Superiority of trans-oral over trans-nasal sampling in detecting Streptococcus pneumoniae colonization in adults","volume":"8","author":"K Trzcinski","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"e0119875","DOI":"10.1371\/journal.pone.0119875","article-title":"Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness","volume":"10","author":"CL Krone","year":"2015","journal-title":"PloS one"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"34888","DOI":"10.1038\/srep34888","article-title":"Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children","volume":"6","author":"AL Wyllie","year":"2016","journal-title":"Scientific reports"},{"issue":"5","key":"ref54","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1086\/381547","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings","volume":"38","author":"G Regev-Yochay","year":"2004","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tim.2012.11.005","article-title":"Influence of bacterial interactions on pneumococcal colonization of the nasopharynx","volume":"21","author":"JR Shak","year":"2013","journal-title":"Trends in microbiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:18:46Z","timestamp":1589001526000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206927"}},"subtitle":[],"editor":[{"given":"Jose","family":"Melo-Cristino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206927","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/409359","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]}}}